期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

α-硫辛酸辅治糖尿病周围神经病变的临床观察 被引量：3

在线阅读 下载PDF
导出
摘要 目的观察α-硫辛酸辅治糖尿病周围神经病变的临床效果。方法将78例糖尿病周围神经病变患者随机分为治疗组和对照组各39例。对照组在常规治疗基础上采用甲钴胺治疗;治疗组在常规治疗基础上采用α-硫辛酸治疗。结果治疗后2组运动神经中正中神经、腓神经和胫神经传导速度均高于治疗前,且治疗组高于对照组,差异均有统计学意义(P<0.05)。治疗后2组感觉神经中正中神经和腓神经传导速度均高于治疗前,且治疗组高于对照组,差异均有统计学意义(P<0.05)。结论α-硫辛酸辅治糖尿病周围神经病变临床效果显著,可提高患者运动神经和感觉神经传导速度,且无不良反应,值得临床推广应用。
作者 章志 熊艳
机构地区 南昌大学第四附属医院内分泌科
出处 《临床合理用药杂志》 2013年第25期51-51,共1页 Chinese Journal of Clinical Rational Drug Use
关键词 硫辛酸 糖尿病 神经病变 周围 辅助治疗
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献4

二级参考文献53

  • 1张德刚,赵瑛,夏培金,黄霄群,刘志民.褪黑素对糖尿病周围神经病变大鼠氧化应激的作用[J].标记免疫分析与临床,2006,13(4):221-224. 被引量：8
  • 2Standards of Medical Care in Diabetes--2008 DIABETES CARE, VOLUME 31, SUPPLEMENT 1, IANUARY 2008,
  • 3Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol, 1995, 38(6): 869-880
  • 4Tesfaye S, Stevens LK, Stephenson lM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia, 1996, 39(11): 1377-1384.
  • 5Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care, 2005, 28: 956-962.
  • 6Hotta N, Kawamori R, Atsumi Y, et al. Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat ADCT Study Group. Diabet Med, 2008, 25(7): 818-825.
  • 7Hotta N, Akanuma Y, Kawamori R, et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial. Diabetes Care, 2006, 29: 1538-1544.
  • 8Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst Rev, 2007, 17(4): CD004572.
  • 9Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with alpha- lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia, 1995, 38(12): 1425-1433.
  • 10Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN Ⅱ). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res, 1999, 31(3): 171-179.

共引文献57

同被引文献32

  • 1陈令成,秦绪丽,秦泗明.血栓通治疗血栓性静脉炎36例[J].陕西中医,2006,27(5):529-530. 被引量：6
  • 2Hosseini A,Abdollahi M.Diabetic neuropathy and oxidative stress:therapeutic perspectives[M]Oxid Med Cell Longev,2013:9.
  • 3Dyck PJ,Kratz KM,Karnes JL,et al.The The prevalence by staged severity of various types of diabetic neuropathy,retinopathy,and nephropathy in a population-based cohort:the Rochester Diabetic Neuropathy Study[J].Neurology,1993,43(11):2345.
  • 4Malik RA,Tesfaye S,Newrick PG,et al.Sural nerve pathology in diabetic patients with minimal but progressive neuropathy[J].Diabetologia,2005,48(3):578-585.
  • 5Dyck PJ,Davies JI,Clark VM,et al.Modeling chronic glycemic exposure variables as correlate and predictors of microvascular complications of diabetes[J].Prog Neurobiol,2006,29(10):2282-2288.
  • 6pasnoor M,dimachkie MVI,Kluding P,et al.Diabetic neuropathy part 1:Overview and symmetric phenotypes[J].Ne u r ol Clin,2013,31(2):425-445.
  • 7张日辉,郭峰.肌电图测试分析及在运动实践中应用研究进展[C].2011年中国生理学会运动生理学专业委员会会议暨“运动与骨骼肌”学术研讨会,2012-10-31.
  • 8高卫东,刘秀玲,张志群.动态血糖监测与胰岛素泵在2型糖尿病治疗中的效果观察及对部分指标的影响分析[J].四川医学,2013,34(9):1459-1460.
  • 9Little AA,Edwadrs JL,Feldman EL.Diabetieneuorpathies[J].Paret Neurol,2007,7(2):82-92.
  • 10Schror K,Hohlfeld T.Mechanisms of anti 2ischemic action of prostaglandin E1 in peripheral afterial occlusive disease[J].Vasa,2004,33(3):119-124.

引证文献3

二级引证文献18

临床合理用药杂志
2013年 第25期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部